The partial thromboplastin time: Defining an era in coagulation

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2267-2270

  White, G C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR;

ART; ARTICLE; BLOOD CLOTTING; HEMOPHILIA A; HISTORY; HUMAN; METHODOLOGY; PARTIAL THROMBOPLASTIN TIME; STANDARD;

BLOOD COAGULATION; BLOOD COAGULATION FACTORS; HEMOPHILIA A; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PARTIAL THROMBOPLASTIN TIME; PORTRAITS;

EID: 4444247754     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00459.x     Document Type: Note

References (19)

1. Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-hemophilic factor on one-stage clotting tests: a presumptive test for hemophilia and a simple one-stage anti-hemophilic factor assay procedure. J Lab Clin Med 1953; 41: 637-47.
2. Patek JAJ, Stetson RH, Hemophilia. I. The abnormal coagulation of the blood and its relation to the blood platelets. J Clin Invest 1936; 15:531-42.
3. Owen PA. The coagulation of blood. Investigations on a new clotting factor. Ada Med Scand 1947; 194 (Suppl.): 521-49.
4. Alexander B, Goldstein R, Landwehr G, Cook CD. Coagulation serum prothrombin conversion accelerator (SPCA) deficiency. A hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fraction. J Clin Invest 1951; 30: 596-608.
5. Aggeler PM, White SG, MB. Glendening , Page EW, Leake TB, Bates G. Plasma thromboplastin component (PTC) deficiency: a new disease resembling hemophilia. Proc Soc Exp Biol Med 1952; 79: 692-4.
6. Biggs R, Douglas AS, Macfarlane RG, Dacie JV, Pitney WR, Merskey C, O'Brien JR. Christmas disease. A condition previously mistaken for haemophilia. Br Med J 1952; 2: 1378-82.
7. Shulman I, Smith CH. Hemorrhagic disease in an infant due to deficiency of a hitherto undescribed clotting factor. Blood 1952; 7: 794-807.
8. Rosenthal RL, Dreskinoff OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82: 171-4.
9. Brinkhous KM. A study of the clotting defect in hemophilia: The delayed formation of thrombin. Am J Med Sci 1939; 198: 509-16.
10. Webster WP, Roberts HR, Thelin GM, Wagner RH, Brinkhous KM. Clinical use of a new glycine-precipitated antihemophilic fraction. Am J Med Sci 1965; 250: 643-51.
11. Warner ED, Brinkhous KM, Smith HP. The titration of prothrombin in certain plasmas (Abstract). Arch Pathol 1934; 18: 857.
12. Quick AJ. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73-4.
13. Langdell RD. Partial thromboplastin time method for determination of antihemophilic plasma. In: K M Brinkhous, ed. The Hemophilias. Washington, DC. University of North Carolina Press, 1964: p. 11-4.
14. Bell WN, Alton HG. A brain extract as a substitue for platelet suspen sions in the thromboplastin generation time. Nature 1954; 174: 880-1.
15. Mills CA. Blood clotting studies in hemophilia. Am J Physiol 1926; 76: 632-41.
16. Eagle H. Studies on blood coagulation. IV. The nature of the clotting deficiency in hemophilia. J Gen Physiol 1935; 18: 813-9.
17. Dam H, Venndt H. Observations on the coagulation of blood plasma in haemophilia. Lancet 1940; 238: 70-2.
18. Margolis J. The kaolin clotting time. A rapid one-stage method for diagnosis of coagulation defects. J Clin Pathol Lond 1958; 11: 406-9.
19. Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Path 1961; 36: 212-9.